logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

“One-by-one, TB took everything away from me”: A photovoice exploration of stigma in women with drug-resistant tuberculosis in Mumbai

Mahbub T, Mathur T, Isaakidis P, Daftary A
2023-03-28 • Affilia
2023-03-28 • Affilia
Stigma related to drug-resistant tuberculosis (DR-TB), one of the world's most severe infectious diseases, is a major barrier to TB elimination particularly for women living in settings ...
Journal Article
|
Review

Re-Inventing Adherence: Toward a Patient-Centered Model of Care for Drug-Resistant Tuberculosis and HIV

ODonnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR,  et al.
2016-04-01 • International Journal of Tuberculosis and Lung Disease
2016-04-01 • International Journal of Tuberculosis and Lung Disease
Despite renewed focus on molecular tuberculosis (TB) diagnostics and new antimycobacterial agents, treatment outcomes for patients co-infected with drug-resistant TB and human immunodefi...
Journal Article
|
Research

"When treatment is more challenging than the disease": A qualitative study of MDR-TB patient retention

Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK, Das M,  et al.
2016-03-09 • PLOS One
2016-03-09 • PLOS One
BACKGROUND
One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU).

OBJECTIVE
Conference Material
|
Abstract

Photovoice: addressing stigma among people living with drug-resistant tuberculosis in India

Mahbub T, Mathur T, Holmgren J, Ravi S, Das M,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation
WHAT CHALLENGE OR OPPORTUNITY DID YOU TRY TO ADDRESS? WERE EXISTING SOLUTIONS NOT AVAILABLE OR NOT GOOD ENOUGH?
Individuals with multidrug resistant tuberculosis (MDR-TB) undergo on...
Conference Material
|
Slide Presentation

Photovoice: addressing stigma among people living with drug-resistant tuberculosis in India

Mahbub T, Mathur T, Holmgren J, Ravi S, Das M,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation